News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Advaxis, Inc. To Present At The 2nd Annual Sachs Cancer Bio Partnering & Investment Forum


3/13/2014 9:09:12 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

PRINCETON, N.J., March 13, 2014 (GLOBE NEWSWIRE) -- Advaxis, Inc. (Nasdaq:ADXS), a biotechnology company developing the next generation of cancer immunotherapies, today announced that the company will present at the 2nd Annual Sachs Cancer Bio Partnering & Investment Forum on Wednesday, March 19 at the New York Academy of Sciences. Robert G. Petit, Ph.D., Chief Scientific Officer of Advaxis, will serve on an expert panel titled "Immunotherapies and Cancer Vaccines" at 11:45am and Daniel J. O'Connor, Chief Executive Officer of Advaxis, will present an update on the Company at 1:30pm.

Help employers find you! Check out all the jobs and post your resume.

Read at GlobeNewswire


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES